Literature DB >> 15044409

What is the most relevant standard of success in assisted reproduction? The importance of informed choice.

William Buckett1, Seang Lin Tan.   

Abstract

Whilst there is a need to emphasize the birth rates of healthy infants when reporting success rates following infertility treatment, is 'the singleton term gestation per cycle started' the most appropriate measure? Although there are many ways to measure the efficacy of medical intervention, none of these exclude from the 'successes' those in whom complications have occurred. The safe delivery of healthy twins at term, while possibly not the ideal outcome, should still be regarded as a treatment success. Although multiple pregnancy, in particular high order multiple pregnancy, continues to be a major problem associated with assisted reproductive treatments and also with ovulation induction, appropriate counselling concerning the risks of twin and triplet pregnancies will allow couples to make informed choices and allow clinicians to continue to individualize treatment plans.

Entities:  

Keywords:  Genetics and Reproduction

Mesh:

Year:  2004        PMID: 15044409     DOI: 10.1093/humrep/deh206

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  3 in total

1.  Number of embryos transferred after in vitro fertilization and good perinatal outcome.

Authors:  Dmitry M Kissin; Aniket D Kulkarni; Vitaly A Kushnir; Denise J Jamieson
Journal:  Obstet Gynecol       Date:  2014-02       Impact factor: 7.661

2.  Success of frozen embryo transfer: Does the type of gonadotropin influence the outcome?

Authors:  Hesham Al-Inany; Pieter van Gelder
Journal:  Int J Womens Health       Date:  2010-08-09

3.  Efficacy and safety of recombinant human follicle-stimulating hormone in patients undergoing in vitro fertilization-embryo transfer.

Authors:  Linli Hu; Songying Zhang; Song Quan; Jieqiang Lv; Weiping Qian; Yuanhua Huang; Weiying Lu; Yingpu Sun
Journal:  Aging (Albany NY)       Date:  2020-03-25       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.